Agafonova Nataliya 4
4 · Longeveron Inc. · Filed Jul 17, 2025
Insider Transaction Report
Form 4
Longeveron Inc.LGVN
Agafonova Nataliya
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-07-15+34,000→ 34,000 totalExercise: $1.47Exp: 2035-07-15→ Class A Common Stock (34,000 underlying) - Award
Class A Common Stock
2025-07-15+102,000→ 238,697 total
Footnotes (3)
- [F1]Represents the award of time-based vesting Restricted Stock Units (RSUs).
- [F2]Includes RSUs subject to future vesting.
- [F3]The option vests quarterly over a three year period beginning on October 1, 2025.